Cargando…

Reply to Li, A.-H.; Chiu, Y.-L. Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on “Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. J. Clin. Med. 2022, 11, 5612”

Detalles Bibliográficos
Autores principales:	Chen, Yi-Chun, Yu, Ben-Hui, Chiou, Wen-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821739/ https://www.ncbi.nlm.nih.gov/pubmed/36614972 http://dx.doi.org/10.3390/jcm12010171

Ejemplares similares

Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. J. Clin. Med. 2022, 11, 5612
por: Li, Ai-Hsien, et al.
Publicado: (2022)

Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
por: Chen, Yi-Chun, et al.
Publicado: (2022)

Reply to Chen et al. Improvements in Outcomes and Expanding Indications for the Commando Procedure. Comment on “Giambuzzi et al. Surgical Aortic Mitral Curtain Replacement: Systematic Review and Metanalysis of Early and Long-Term Results. J. Clin. Med. 2021, 10, 3163”
por: Giambuzzi, Ilaria, et al.
Publicado: (2022)

Reply to Alt et al. Comment on “Lunz et al. Impact and Modification of the New PJI-TNM Classification for Periprosthetic Joint Infections. J. Clin. Med. 2023, 12, 1262”
por: Lunz, Andre, et al.
Publicado: (2023)

Chinese mathematics in the thirteenth century: the Shu-shu chiu-chang of Ch'in Chiu-shao
por: Libbrecht, Ulrich
Publicado: (1973)

COVID-19-induced acute kidney injury and chronic kidney disease: comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Reply to Comment on Chen, J., Su, Y., Si, H., Chen, J. Managerial Areas of Construction and Demolition Waste: A Scientometric Review. Int. J. Environ. Res. Public Health 2018, 15 (11), 2350, doi:10.3390/ijerph15112350
por: Chen, Jianguo, et al.
Publicado: (2019)

Reply to Farahani, P.; Wahid, L. Comment on “Viderman et al. Remote Monitoring of Chronic Critically Ill Patients after Hospital Discharge: A Systematic Review. J. Clin. Med. 2022, 11, 1010”
por: Viderman, Dmitriy, et al.
Publicado: (2023)

The association between acute kidney injury in renal infarction and progression to chronic kidney disease
por: Oh, Yun Kyu
Publicado: (2016)

COVID-19-induced acute kidney injury and chronic kidney disease: correspondence response
por: Musso, Carlos G., et al.
Publicado: (2022)

Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on “Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158”
por: Hughes, Derralynn A., et al.
Publicado: (2023)

Reply to Fernandez-Vigo et al. Comment on “Torrellas et al. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser. J. Clin. Med. 2023, 12, 1127”
por: Torrellas, Beatriz, et al.
Publicado: (2023)

Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Reply to Comments: Comparison of Methods Study between a Photonic Crystal Biosensor and Certified ELISA to Measure Biomarkers of Iron Deficiency in Chronic Kidney Disease Patients
por: Peterson, Ross D., et al.
Publicado: (2020)

Pulmonary hypertension in chronic kidney disease: what could change the fate?
por: Lee, Soo Bong
Publicado: (2016)

Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”
por: Calfon-Peretz, Ortal, et al.
Publicado: (2022)

Reply to “Concerns about Transmission Electron Micrographs in Recent Article by Chen and Williams”
por: Neal Williams, Henry
Publicado: (2012)

Reply to Kalfert, D. Comment on “Zwierz et al. The Long-Term Effects of 12-Week Intranasal Steroid Therapy on Adenoid Size, Its Mucus Coverage and Otitis Media with Effusion: A Cohort Study in Preschool Children. J. Clin. Med. 2022, 11, 507”
por: Zwierz, Aleksander
Publicado: (2022)

Reply to Jensen, O.K. On the Use of Quantitative Sensory Testing to Estimate Central Sensitization in Humans. Comment on “Schuttert et al. The Definition, Assessment, and Prevalence of (Human Assumed) Central Sensitisation in Patients with Chronic Low Back Pain: A Systematic Review. J. Clin. Med. 2021, 10, 5931”
por: Schuttert, Ingrid, et al.
Publicado: (2022)

Is there an association between quadriceps thickness and functional capacity in patients with chronic kidney disease?
por: de Paula, Bruno Lionardo, et al.
Publicado: (2022)

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022)

Reply to Supady et al. On the Use of Hemadsorption with CytoSorb in Patients with Septic Shock. Comment on “Kogelmann et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J. Clin. Med. 2021, 10, 2939”
por: Kogelmann, Klaus, et al.
Publicado: (2022)

Reply to Böning et al. Comment on “Ceruti et al. Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients. J. Clin. Med. 2022, 11, 788”
por: Ceruti, Samuele, et al.
Publicado: (2022)

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511”
por: Potestio, Luca, et al.
Publicado: (2022)

Reply to Schimmelbusch, K.J.; Collison, F.T. Comment on “Rosa et al. Optic Nerve Drusen Evaluation: A Comparison between Ultrasound and OCT. J. Clin. Med. 2022, 11, 3715”
por: Rosa, Nicola, et al.
Publicado: (2023)

Reply to de Reuver et al. Comment on “Grivas et al. Morphology, Development and Deformation of the Spine in Mild and Moderate Scoliosis: Are Changes in the Spine Primary or Secondary? J. Clin. Med. 2021, 10, 5901”
por: Grivas, Theodoros B., et al.
Publicado: (2022)

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
por: Boelaert, Jente, et al.
Publicado: (2016)

Reply to Weiss, H.-R. Comment on “Costa et al. The Effectiveness of Different Concepts of Bracing in Adolescent Idiopathic Scoliosis (AIS): A Systematic Review and Meta-Analysis. J. Clin. Med. 2021, 10, 2145”
por: Costa, Lorenzo, et al.
Publicado: (2022)

Reply to Comment on Nogueira, P.J., et al. “The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases”. J. Clin. Med. 2020, 9, 2368
por: Nogueira, Paulo Jorge, et al.
Publicado: (2020)

Estimation of the Loading Dose for Target-Controlled Infusion of Dexmedetomidine. Reply to Eleveld et al. Comment on “Morse et al. A Universal Pharmacokinetic Model for Dexmedetomidine in Children and Adults. J. Clin. Med. 2020, 9, 3480”
por: Morse, James D., et al.
Publicado: (2021)

Reply to Ducreux, B.; Fauque, P. Comment on “Cannarella et al. DNA Methylation in Offspring Conceived after Assisted Reproductive Techniques: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 5056”
por: Cannarella, Rossella, et al.
Publicado: (2022)

Reply to Marino et al. Choroidal Thickness Measurements in the Case of Diabetic Macular Edema. Comment on “Amjad et al. Choroidal Thickness in Different Patterns of Diabetic Macular Edema. J. Clin. Med. 2022, 11, 6169”
por: Amjad, Rida, et al.
Publicado: (2023)

Reply to Cione et al. Comment on “Moshirfar et al. Accuracy of Six Intraocular Lens Power Calculations in Eyes with Axial Lengths Greater than 28.0 mm. J. Clin. Med. 2022, 11, 5947”
por: Moshirfar, Majid, et al.
Publicado: (2023)

Reply to “Comment on Fitria et al. ‘Environmental and Occupational Risk Factors Associated with Chronic Kidney Disease of Unknown Etiology in West Javanese Rice Farmers, Indonesia’ Int. J. Environ. Res. Public Health, 2020, 17, 4521”
por: Fitria, Laila, et al.
Publicado: (2020)

Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on “Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11, 860”
por: Volod, Oksana, et al.
Publicado: (2023)

Reply to Meule, A. Comment on “Calugi et al. The Role of Weight Suppression in Intensive Enhanced Cognitive Behavioral Therapy for Adolescents with Anorexia Nervosa: A Longitudinal Study. Int. J. Environ. Res. Public Health 2023, 20, 3221”
por: Calugi, Simona, et al.
Publicado: (2023)

Reply to Wostyn, P. Could Young Cerebrospinal Fluid Combat Glaucoma? Comment on “Lee et al. Association between Optic Nerve Sheath Diameter and Lamina Cribrosa Morphology in Normal-Tension Glaucoma. J. Clin. Med. 2023, 12, 360”
por: Lee, Seung Hyen, et al.
Publicado: (2023)

Reply to Stanojcic et al. Comment on “Fernández-Vigo et al. Objective Classification of Glistening in Implanted Intraocular Lenses Using Optical Coherence Tomography: Proposal for a New Classification and Grading System. J. Clin. Med. 2023, 12, 2351”
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2023)

Live long and PROSPERO: A comment on Chiu and coworkers
por: Tully, Phillip J., et al.
Publicado: (2021)

Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on “Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. J. Clin. Med. 2023, 12, 1412”
por: Katz, Moshe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f0dqb9ho7oa92ccc83628a3u47